Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-005838

EVP and Chief Medical Officer sold 1,657 shares at $66.30 ($109,859)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-30 Sale : show line 1 in the form −1,657 $66.30 $109,859 36,759 D
Open-market sales · 1,657 sh · avg $66.30 · $109,859
Loading xslF345X03/doc4.xml…